47 Citaten (Scopus)
353 Downloads (Pure)


Asthma is an inflammatory airway disease that is estimated to affect 339 million people globally. The symptoms of about 5-10% of patients with asthma are not adequately controlled with current therapy, and little success has been achieved in developing drugs that target the underlying mechanisms of asthma rather than suppressing symptoms. Over the past 3 years, well powered genetic studies of asthma have increased the number of independent asthma-associated genetic loci to 128. In this Series paper, we describe the immense progress in asthma genetics over the past 13 years and link asthma genetic variants to possible drug targets. Further studies are needed to establish the functional significance of gene variants associated with asthma in subgroups of patients and to describe the biological networks within which they function. The genomics-guided discovery of plausible drug targets for asthma could pave the way for the repurposing of existing drugs for asthma and the development of new treatments.

Originele taal-2English
Pagina's (van-tot)1045-1056
Aantal pagina's13
TijdschriftThe Lancet. Respiratory Medicine
Nummer van het tijdschrift10
Vroegere onlinedatum7-sep.-2020
StatusPublished - okt.-2020

Citeer dit